CompletedPhase 4

Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD

China139 participantsStarted 2004-06

Plain-language summary

The purpose of this study was to explore the impacts of different continuous ambulatory peritoneal dialysis (CAPD) dosage (three 2-Liter exchanges CAPD vs. four 2-Liter exchanges CAPD) on residual kidney function, technique survival, patient survival, and peritonitis in incident Chinese peritoneal dialysis patients.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * incident CAPD patients aged 18 to 80 years * GFR ≥ 2 ml/min and Uvol ≥ 500 ml/day Exclusion Criteria: * have a history of maintenance hemodialysis or renal transplantation * anticipated life expectancy less than 6 months * with active malignancy, acute infection, significant heart failure or in other severe conditions * unable to give informed consent

What they're measuring

Residual kidney function including glomerular filtration rate (GFR), daily urine voume (Uvol), and anuria-free survival.

Timeframe: Up to 24 months after CAPD initiation

Trial details

NCT IDNCT01637792

SponsorShanghai Jiao Tong University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-08

View on ClinicalTrials.gov More End Stage Renal Disease trials